Sunovo Capital

Sunovo Capital invests across seed, start-up, and growth stages. The firm typically enters after initial product-market fit has been established, providing capital to scale operations within China or support regional expansion across Asia. Its mandate spans both early-stage venture and growth equity.

The firm concentrates on enterprise software, artificial intelligence and machine learning, industrial technology, healthcare services, and consumer sectors. Sunovo favors technology-enabled businesses with domestic Chinese market traction and, in certain cases, international expansion potential.

Sunovo's Hangzhou location provides access to the Yangtze River Delta innovation ecosystem, including Alibaba alumni networks and Zhejiang province's manufacturing and technology base. This geographic anchoring differentiates the firm from venture investors concentrated in Beijing, Shanghai, and Shenzhen, granting preferential access to founders in eastern China's private-sector economy.

Sunovo is primarily a domestic China investor, though it has facilitated cross-border structuring for portfolio companies pursuing international expansion or secondary listings. The firm's investment committee evaluates opportunities in other Asian markets on a selective basis, but the core mandate remains Chinese technology and healthcare companies.

Sunovo Capital does not publicly disclose its limited partner base or fund-level details. As a private, independent firm based in Hangzhou, its funding sources are not a matter of public record. Institutional allocators conducting due diligence would need to request this information directly.